These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 676122)

  • 41. Trends in cardiogenic shock: report from the SHOCK Study. The SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?
    Carnendran L; Abboud R; Sleeper LA; Gurunathan R; Webb JG; Menon V; Dzavik V; Cocke T; Hochman JS
    Eur Heart J; 2001 Mar; 22(6):472-8. PubMed ID: 11237542
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modified paper chromatographic method for assay of myocardial depressant factor.
    Yamada T; Pettit GW
    Circ Shock; 1977; 4(4):379-86. PubMed ID: 598007
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Treatment of cardiogenic shock in myocardial infarction with intraaortic counterpulsation].
    Rumiński W; Markiewicz M; Koziara D; Grzywna R; Lakomski B
    Kardiol Pol; 1993 May; 38(5):323-6. PubMed ID: 8366639
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Incidence and prognosis of early primary cardiogenic shock in myocardial infarction].
    Himbert D; Karrillon GJ; Hvass U; Juliard JM; Steg PG; Aumont MC; Gourgon R
    Arch Mal Coeur Vaiss; 1994 Dec; 87(12):1679-84. PubMed ID: 7786107
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Plasma kallikrein-kinin system in patients with uncomplicated sepsis and septic shock--comparison with cardiogenic shock.
    Martínez-Brotóns F; Oncins JR; Mestres J; Amargós V; Reynaldo C
    Thromb Haemost; 1987 Aug; 58(2):709-13. PubMed ID: 3672421
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Treatment of cardiogenic shock in acute myocardial infarction and postoperative low cardiac output].
    Kural S; Beaufils P
    Schweiz Med Wochenschr; 1983 Aug; 113(33):1123-8. PubMed ID: 6623032
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A comparison of plasma renin activity levels in patients with and without congestive heart failure after myocardial infarction.
    Sanders JB; Cunningham SG; Knowlton CG
    Heart Lung; 1985 Jan; 14(1):1-8. PubMed ID: 3881367
    [No Abstract]   [Full Text] [Related]  

  • 48. [Cardiogenic shock after myocardial infarction].
    Allemann U
    Schweiz Med Wochenschr; 1972 Jul; 102(28):994-7. PubMed ID: 5049605
    [No Abstract]   [Full Text] [Related]  

  • 49. [Differential diagnosis and the pathogenesis of true cardiogenic shock in acute myocardial infarct].
    Ganelina IE; Vol'pert EI
    Anesteziol Reanimatol; 1978; (4):66-8. PubMed ID: 697108
    [No Abstract]   [Full Text] [Related]  

  • 50. [Ventricular septal rupture and cardiogenic shock in the myocardial infarction case presenting with fever and leukocytosis].
    Tanriverdi O
    Anadolu Kardiyol Derg; 2007 Dec; 7(4):453. PubMed ID: 18065354
    [No Abstract]   [Full Text] [Related]  

  • 51. Studies on low molecular weight inotropic plasma substances in prolonged hypovolemic traumatic shock.
    Hallström S; Vogl C; Krösl P; Redl H; Schlag G
    Prog Clin Biol Res; 1987; 236A():591-7. PubMed ID: 3615453
    [No Abstract]   [Full Text] [Related]  

  • 52. Trends in acute myocardial infarction complicated by cardiogenic shock, 1979-2003, United States.
    Fang J; Mensah GA; Alderman MH; Croft JB
    Am Heart J; 2006 Dec; 152(6):1035-41. PubMed ID: 17161048
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Prevention and treatment of cardiogenic shock associated with acute myocardial infarct].
    Yamamoto Y
    Kango Gijutsu; 1986 May; 32(7):828-32. PubMed ID: 3637342
    [No Abstract]   [Full Text] [Related]  

  • 54. [Pathogenesis and clinical aspects of shock in myocardial infarct].
    Moiseev SG; Ershova NV
    Kardiologiia; 1970 Jul; 10(7):13-6. PubMed ID: 5491666
    [No Abstract]   [Full Text] [Related]  

  • 55. [Analysis of 57 cases of cardiogenic shock in acute myocardial infarct].
    Zochowski RJ; Ostrzycki A; Korewicki J; Zalewska B; Antoniak T
    Kardiol Pol; 1981; 24(4):259-68. PubMed ID: 7289366
    [No Abstract]   [Full Text] [Related]  

  • 56. [Proceedings: Diagnosis and therapy of cardiogenic shock and cardiac insufficiency caused by acute myocardial infarct].
    Takeshita A
    Fukuoka Igaku Zasshi; 1974 Oct; 65(10):798-9. PubMed ID: 4477108
    [No Abstract]   [Full Text] [Related]  

  • 57. [Late cardiogenic shock].
    Rybachuk IA; Briskin VR; Postolovskiĭ VN
    Vrach Delo; 1980 Oct; (10):13-5. PubMed ID: 7434693
    [No Abstract]   [Full Text] [Related]  

  • 58. Production of a myocardial depressant factor in cardiogenic shock.
    Glenn TM; Lefer AM; Martin JB; Lovett WL; Morris JN; Wangensteen SL
    Am Heart J; 1971 Jul; 82(1):78-85. PubMed ID: 5581723
    [No Abstract]   [Full Text] [Related]  

  • 59. [Characterization of a myocardial depressant factor isolated from dogs with cardiogenic shock].
    Okuda M; Yamada T; Hosono K
    Jpn Circ J; 1973 Aug; 37(8):1009-17. PubMed ID: 4800821
    [No Abstract]   [Full Text] [Related]  

  • 60. Isolation of low-molecular-weight peptides in hemofiltrated patients with cardiogenic shock: a new aspect of myocardial depressant substances.
    Coraim F; Trubel W; Ebermann R; Werner T
    Contrib Nephrol; 1991; 93():237-40. PubMed ID: 1802588
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.